Cas:444796-09-2 2,7-Dibromo-9-phenyl-9H-carbazole manufacturer & supplier

Chemical Name:2,7-Dibromo-9-phenyl-9H-carbazole

CAS.NO:444796-09-2

Synonyms:2,7-Dibromo-9-phenyl-9H-carbazole;2,7-Dibromo-N-phenylcarbazole

Molecular Formula:C₁₈H₁₁Br₂N

Molecular Weight:401.09500

HS Code:

Physical and Chemical Properties:

Melting point:179.0 to 183.0 °C

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:4.93000

Exact Mass:398.92600

LogP:6.30870

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,7-Dibromo-9-phenyl-9H-carbazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,7-Dibromo-N-phenylcarbazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,7-Dibromo-N-phenylcarbazole Use and application,2,7-Dibromo-N-phenylcarbazole technical grade,usp/ep/jp grade.

Related News: In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum. 2,7-Dibromo-9-phenyl-9H-carbazole manufacturer But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone. 2,7-Dibromo-9-phenyl-9H-carbazole supplier Nearly all patients who got the vaccine developed antibodies designed to head off the spread of abnormal tau while leaving healthy tau proteins intact, Novak said. 2,7-Dibromo-9-phenyl-9H-carbazole vendor Nearly all patients who got the vaccine developed antibodies designed to head off the spread of abnormal tau while leaving healthy tau proteins intact, Novak said. 2,7-Dibromo-9-phenyl-9H-carbazole factory A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters.